Home Search
viaskin - search results
If you're not happy with the results, please do another search
DBV Completes Phase III Study of Peanut Patch
The phase III trial was designed to assess the safety and routine clinical use of Viaskin Peanut.
Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of 2017
The study received higher-than-expected patient demand.
Study: Peanut Immunotherapy Significantly Reduces Risks Due to Cross-Contact in Common Packaged Foods
The study model used common packaged foods such as cookies, ice cream, and doughnuts as references.
Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis
The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.
Nestlé Partners with DBV to Develop Milk Allergy Test
The world's largest food business forays into allergy diagnostic services to help sell infant formula.
Breakthrough Food Allergy Therapies and the Big Business Behind Them
What it means to be a breakthrough therapy, who is developing them, how they work, and the (big) business drivers behind them.
Peanut Patch Receives FDA's Breakthrough Therapy Designation
The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.
Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.
We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.
Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.
Please see our Terms of Service and Privacy Policy.
Copyright ©2011-2024 SnackSafely.com, Inc — All rights reserved